These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 349191)

  • 1. Screening of new and novel beta-lactam antibiotics.
    Aoki H; Kunugita K; Hosoda J; Imanaka H
    Jpn J Antibiot; 1977 Dec; 30 Suppl():207-17. PubMed ID: 349191
    [No Abstract]   [Full Text] [Related]  

  • 2. [beta-lactamase inhibitors].
    Navashin SM; Nikolaeva TI; Rozenfel'd GS
    Antibiotiki; 1980 Jan; 25(1):51-67. PubMed ID: 6986839
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress of beta-lactam antibiotics. Special reference to monobactam (author's transl)].
    Yokota K
    Jpn J Antibiot; 1981 Dec; 34(12):1525-39. PubMed ID: 7038187
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for beta-lactam antibiotics using a mutant of Pseudomonas aeruginosa.
    Kitano K; Nara K; Nakao Y
    Jpn J Antibiot; 1977 Dec; 30 Suppl():239-45. PubMed ID: 418199
    [No Abstract]   [Full Text] [Related]  

  • 5. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of beta-lactam nucleoside chimera via Kinugasa reaction and evaluation of their antibacterial activity.
    Basak A; Pal R
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2015-8. PubMed ID: 15808459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective screening for natural beta-lactam antibiotics].
    Ivanitskaia LP
    Antibiotiki; 1983 Feb; 28(2):117-36. PubMed ID: 6340597
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformation and activity of beta-lactam antibiotics.
    Rao VS; Vasudevan TK
    CRC Crit Rev Biochem; 1983; 14(3):173-206. PubMed ID: 6354584
    [No Abstract]   [Full Text] [Related]  

  • 9. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
    Newsom SW; Marshall MJ; Harris AM
    J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
    [No Abstract]   [Full Text] [Related]  

  • 10. SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
    Papagiannitsis CC; Loli A; Tzouvelekis LS; Tzelepi E; Arlet G; Miriagou V
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2185-8. PubMed ID: 17353248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance and beta-lactam antibiotic inactivation by bacteria isolated from clinical materials].
    Tomioka H; Uchida H; Minoura Y; Kameoka Y; Hayashi N
    Rinsho Byori; 1974 Oct; 22(10 Suppl):349. PubMed ID: 4615196
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid.
    Easton CJ; Knowles JR
    Biochemistry; 1982 Jun; 21(12):2857-62. PubMed ID: 7049231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli.
    Richmond MH
    Scand J Infect Dis Suppl; 1978; (13):11-5. PubMed ID: 356180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
    J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the activities of beta lactamase inhibitors by nuclear magnetic resonance spectrometry].
    O'hara K; Shiomi Y; Kono M
    Jpn J Antibiot; 1983 Oct; 36(10):2763-8. PubMed ID: 6371290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual pro-drugs of beta-lactam antibiotics and beta-lactamase inhibitors.
    Baltzer B; Binderup E; von Daehne W; Godtfredsen WO; Hansen K; Nielsen B; Sørensen H; Vangedal S
    J Antibiot (Tokyo); 1980 Oct; 33(10):1183-92. PubMed ID: 6969724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.
    Papp-Wallace KM; Bajaksouzian S; Abdelhamed AM; Foster AN; Winkler ML; Gatta JA; Nichols WW; Testa R; Bonomo RA; Jacobs MR
    Diagn Microbiol Infect Dis; 2015 May; 82(1):65-9. PubMed ID: 25737290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on beta-lactam antibiotics V. Effect on antimicrobial activity of 2- and/or 3-methyl group (S) in a cephem nucleus.
    Takaya T; Tozuka Z; Takasugi H; Hamiya T; Nakano H
    J Antibiot (Tokyo); 1982 May; 35(5):585-8. PubMed ID: 7050063
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of O8-antigen in altering beta-lactam antibiotic susceptibilities in Escherichia coli.
    Sarkar SK; Ghosh AS
    FEMS Microbiol Lett; 2008 May; 282(1):59-64. PubMed ID: 18328080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.